Abstract

BackgroundInjection of adipose-derived mesenchymal stromal cells (ASCs) into knee joints after induction of experimental inflammatory osteoarthritis (CiOA) reduces development of joint pathology.1 This protection is only achieved when ASCs are...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
IL-1β-Mediated Activation of Adipose-Derived Mesenchymal Stromal Cells Results in PMN Reallocation and Enhanced Phagocytosis: A Possible Mechanism for the Reduction of Osteoarthritis Pathology
Johannes Roth ... Arjen B Blom
Frontiers in Immunology | VOL. 10
Johannes Roth, et. al.Johannes Roth ... Arjen B Blom
27 May 2019
03.09 Local application of adipose-derived mesenchymal stromal cells in experimental inflammatory oa results in interleukin-1β-mediated attraction of pmns and reduced s100a8/a9 release
Annet Slöetjes ... Stephanie Van Dalen
Annals of the Rheumatic Diseases | VOL. 76
Annet Slöetjes, et. al.Annet Slöetjes ... Stephanie Van Dalen
01 Mar 2017
Local application of adipose-derived mesenchymal stromal cells in experimental inflammatory OA results in interleukin-1β-mediated attraction of PMNs and reduced S100A8/A9 release
B Walgreen ... M.M Van Helsen
Osteoarthritis and Cartilage | VOL. 25
B Walgreen, et. al.B Walgreen ... M.M Van Helsen
01 Apr 2017
THU0033 Local injection of adipose-derived mesenchymal stromal cells in experimental inflammatory oa results in interleukin-1β-mediated attraction of pmns and reduced s100a8/a9 release
M Helsen ... P Van Lent
Annals of the Rheumatic Diseases | VOL. 76
M Helsen, et. al.M Helsen ... P Van Lent
01 Jun 2017
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers